New research has found that reductions in the severity of delusions in patients with schizophrenia-spectrum disorders recovering from an acute psychotic episode were significantly associated with ...

Mr. T was in his late 50s and being treated for schizophrenia, noninsulin-dependent diabetes, and hypertension. He had lived in the same assisted-living facility for the past four years and had ...

In a study published online in the Schizophrenia Bulletin, researchers from Dr. Wang Wei's lab at the Center for Excellence in Brain Science and Intelligence Technology of the Chinese Academy of ...

A real-world switch study shows lumateperone improves metabolic markers while maintaining symptom control in stable ...

Researchers in Norway recently examined the effects of strength training on the long-term clinical care of outpatients with schizophrenia. Compared to a control group enrolled in the same strength ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kane: We're going ...

Oct. 12 (UPI) --A new study from Case Western Reserve University suggests a major shift in schizophrenia treatment -- one that focuses on helping patients better interpret social cues. "We've been ...

A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...

Advocating for rights for people with schizophrenia is a tough lifestyle. In fact, there are only a handful of activists in the United States who have successfully executed writing a memoir, starting ...